{"SPECIMEN TYPE": "SPECIMEN TYPE Block", "SPECIMEN SITE": "SPECIMEN SITE Lung", "DATE OF COLLECTION": "DATE OF COLLECTION 16 July 2021", "REPORT DATE": "26 Aug 2021", "Biomarker Findings": ["Microsatellite status - MSI-High", "Tumor Mutational Burden - 34 Muts/Mb", ""], "Genomic Findings": ["For a complete list of the genes assayed, please refer to the Appendix.", "ERBB2 G776>VC", "ATM S2408L", "CTNNB1 S45del", "ASXL1 G645fs*58, R549fs*2", "CUL3 L210fs*20", "FLCN R477*", "FUBP1 S11fs*43", "PTPRO Q484fs*14", "SMARCA4 R1243W", ""], "Microsatellite status - MSI-High": [["Atezolizumab", "Cemiplimab", "Durvalumab", "Nivolumab", "Pembrolizumab", "Dostarlimab"], ["Avelumab"]], "Tumor Mutational Burden - 34 Muts/Mb": [["Atezolizumab", "Cemiplimab", "Durvalumab", "Nivolumab", "Nivolumab +", "Ipilimumab", "Pembrolizumab", "Dostarlimab"], ["Avelumab"]], "ERBB2 - G776>VC": [["Afatinib"], ["Ado-trastuzumab", "emtansine", "Fam-trastuzumab", "deruxtecan", "Neratinib", "Trastuzumab", "Trastuzumab +", "Pertuzumab", "Lapatinib 1"]], "ATM - S2408L": [["none"], ["Niraparib", "Olaparib", "Rucaparib", "Talazoparib"]], "CTNNB1 - S45del": [["none", "indicated therapy", "p. 8"], ["none", "NCCN category"]]}